India News | Reported by Vishnu Som, Edited by Anindita Sanyal | Thursday November 11, 2021
Emergency Use Authorisation for the Merck drug Molnupiravir -- an oral antiviral medicine for the treatment of mild-to-moderate COVID-19 -- is likely "within days", Dr Ram Vishwakarma, Chairman of the Covid Strategy Group, CSIR, told NDTV today.
www.ndtv.com